TickerFacts.

BGM Group Ltd. (BGM): Cost of Revenue

Annual figures by period end, from SEC filings.

$31.61M
Year ended 2025-09-30
-18.6%
3-year compound annual growth
-5.7%
5-year compound annual growth
$58.63M2018-09-30: $42.24M2019-09-30: $36.42M2020-09-30: $42.49M2021-09-30: $51.46M2022-09-30: $58.63M2023-09-30: $44.72M2024-09-30: $20.98M2025-09-30: $31.61M$31.61M
2018-09-30 Cost of Revenue (USD) 2025-09-30
Period endedCost of RevenueChange YoYSource filing
2025-09-30$31.61M+50.6%2026-07-21, From 2024-10-01
2024-09-30$20.98M-53.1%2026-07-21, From 2023-10-01
2023-09-30$44.72M-23.7%2026-07-21, From 2022-10-01
2022-09-30$58.63M+13.9%2025-04-03, From 2021-10-01
2021-09-30$51.46M+21.1%2024-02-15, From 2020-10-01
2020-09-30$42.49M+16.7%2023-04-19, From 2019-10-01
2019-09-30$36.42M-13.8%2022-10-13, From 2018-10-01
2018-09-30$42.24Mn/a2021-03-09, From 2017-10-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
BGM Group Ltd. (BGM)2025-09-30$31.61M+50.6%
Lftd Partners Inc. (LIFD)2025-12-31$24.30M-1.1%
Sunshine Biopharma Inc. (SBFM)2025-12-31$24.05M-0.6%
Earth Science Tech, Inc. (ETST)2026-03-31$10.21M+15.8%
Verrica Pharmaceuticals Inc. (VRCA)2024-12-31$2.60M+420.0%
Bioharvest Sciences Inc. (BHST)2025-12-31$14.03M+24.8%
Integrated Biopharma Inc (INBP)2026-06-30$43.07M-11.7%
Cumberland Pharmaceuticals Inc (CPIX)2025-12-31$6.67M+1.2%
Aquestive Therapeutics, Inc. (AQST)2025-12-31$18.55M+3.8%

Compare BGM, LIFD, SBFM, ETST side by side · Screen every company in Pharmaceutical Preparations ↗